Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • Asia Healthcare in...

    Asia Healthcare in talks to acquire Nova IVI Fertility

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-09-26T17:55:54+05:30  |  Updated On 26 Sept 2018 5:55 PM IST
    Asia Healthcare in talks to acquire Nova IVI Fertility

    New Delhi: Asia Healthcare Holdings (AHH), an operating and investment platform founded by TPG Growth, the global middle market and growth equity platform of TPG, announced it has all set to acquire Nova IVI Fertility, one of the largest operators of fertility clinics in India, in a deal said to be worth of $100 Million


    Nova IVI Fertility, backed by Goldman Sachs, New Enterprise Associates and GTI Capital, currently operates 20 centres across the country. Investment bank Lincoln International is handling the transaction, according to the report.


    Nova IVI provides assisted-reproductive therapy treatments such as intrauterine insemination (IUI), in vitro fertilisation (IVF) and andrology services.


    Earlier Medical Dialogues reported that Asia Healthcare Holdings (AHH) has raised USD 50 million from Sheares Healthcare, an investor and provider of healthcare delivery services. Sheares Healthcare, which is wholly owned by Temasek, a global investment company headquartered in Singapore, works closely with portfolio companies to shape healthcare delivery, primarily in Asia, through innovative, appropriate, and patient-focused care.

    Read Also: AHH raises 50 million dollars from Sheares Healthcare

    Asia Healthcare currently holds TPG Growth’s investments in Rhea Healthcare, which runs a hospital chain under the Motherhood brand, and Cancer Treatment Services International.


    AHH will buy stakes from existing private equity investors and promoters including founder Mahesh Reddy, said two people aware of the development told Economic Times
    AHHandrology servicesAsia Healthcare HoldingsCancer Treatment Servicesin vitro fertilisationintrauterine inseminationIUIIVFMotherhood brandNova IVINova IVI FertilityRhea HealthcareTPG

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok